Oncopeptides
Rein Piir is the current Head of Investor Relations at Oncopeptides AB. Rein has over 20 years of experience in the financial and investment industries. Prior to their current position, Mr. Piir served as Executive Vice President of Corporate Affairs and Investor Relations at medivir ab from 2009 to 2015. Rein also served as Chief Financial Officer and Investor Relations at medivir ab from 2001 to 2009. In addition, Mr. Piir has held positions as Head of Life Science Research and Head of Research at carnegie.
Rein Piir holds a bachelors degree from uppsala university.
Rein Piir reports to Anders Martin-Löf, CFO.
This person is not in any offices
Oncopeptides
2 followers
Oncopeptides is a clinical development pharmaceutical company focused on bringing anti-cancer research as treatments for the benefit of patients.